Filing Details
- Accession Number:
- 0000950170-24-069289
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-05 16:05:20
- Reporting Period:
- 2024-06-04
- Accepted Time:
- 2024-06-05 16:05:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886744 | Geron Corp | GERN | Pharmaceutical Preparations (2834) | 752287752 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1270928 | A John Scarlett | C/O Geron Corporation 919 E. Hillsdale Blvd, Suite 250 Foster City CA 94404 | Chairman, President and Ceo | No | No | No | No |
Transaction Summary
| Sold: | 600,000 shares | Avg. Price: $4.00 | Total Value: $2,400,000.00 |
| Number of Shares After Transactions: | 600,000 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-04 | 600,000 | $2.54 | 600,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-04 | 600,000 | $4.00 | 600,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-06-04 | 600,000 | $0.00 | 600,000 | $2.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-02-11 | No | 4 | M | Direct |
Footnotes
- This transaction reflects an exercise and sale of options due to expire on February 11, 2026 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on February 20, 2024.
- Option was fully vested.
Hedge Fund Resource Center Billionaire Hedge Funds
